177
- Sulkowski MS (2008) Viral hepatitis and HIV coinfection. J Hepatol 48:353–367
- Brickman C, Palefsky JM (2015) Human papillomavirus in the HIV-infected host: epidemiol-
ogy and pathogenesis in the antiretroviral era. Curr HIV/AIDS Rep 12:6–15 - Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH (1998) Sexual
transmission and the natural history of human herpesvirus 8 infection. N Engl J Med
338:948–954 - McLaughlin-Drubin ME, Munger K (2008) Viruses associated with human cancer. Biochim
Biophys Acta (BBA)-Mol Basis Dis 1782:127–150 - Qi P, Han J, Lu Y, Wang C, Bu F (2006) Virus-encoded microRNAs: future therapeutic targets.
Cell Mol Immunol 3:411–419 - Yeung ML, Bennasser Y, Le SY, Jeang KT (2005) siRNA, miRNA and HIV: promises and
challenges. Cell Res 15:935–946 - Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL,
Mak RH, Ferrando AA (2005) MicroRNA expression profiles classify human cancers. Nature
435:834–838 - Pfeffer S, Voinnet O (2006) Viruses, microRNAs and cancer. Oncogene 25:6211–6219
- Romani B, Engelbrecht S, Glashoff RH (2010) Functions of tat: the versatile protein of human
immunodeficiency virus type 1. J Gen Virol 91:1–12 - Kim RH, Yochim JM, Kang MK, Shin K-H, Christensen R, Park N-H (2008) HIV-1 tat
enhances replicative potential of human oral keratinocytes harboring HPV-16 genome. Int
J Oncol 33:777 - Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman
VS, Gallo RC, Racz P (2005) Persistence of HIV-1 structural proteins and glycoproteins in
lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A
102:14807–14812 - Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini
S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A,
Capobianchi MR, Ippolito G, Fiorentini S, Blattner WA, Lu W, Gallo RC, Caruso A (2015)
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. Proc Natl Acad Sci U S
A 112:14331–14336 - Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA (2007) AIDS-related cancer and severity of
immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962–972 - Franceschi S, Dal Maso L, Rickenbach M, Polesel J, Hirschel B, Cavassini M, Bordoni A, Elzi
L, Ess S, Jundt G (2008) Kaposi sarcoma incidence in the Swiss HIV cohort study before and
after highly active antiretroviral therapy. Br J Cancer 99:800–804 - Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H,
Hasse B, Levi F, Probst-Hensch NM (2008) Non-Hodgkin lymphoma incidence in the Swiss
HIV cohort study before and after highly active antiretroviral therapy. AIDS 22:301–306 - Hleyhel M, HIV WcotCRGotFHDo (2014) Risk of non-AIDS-defining cancers among HIV-
1- infected individuals in France between 1997 and 2009: results from a French cohort. AIDS
28:2109–2118 - Pacheco Y, Jarrin I, Rosado I, Campins A, Berenguer J, Iribarren J, Rivero M, Muñoz-Medina
L, Bernal-Morell E, Gutiérrez F (2015) Increased risk of non-AIDS-related events in HIV
subjects with persistent low CD4 counts despite cART in the CoRIS cohort. Antivir Res
117:69–74 - Dubrow R, Silverberg MJ, Park LS, Crothers K, Justice AC (2012) HIV infection, aging, and
immune function: implications for cancer risk and prevention. Curr Opin Oncol 24:506 - Crum-Cianflone NF, Hullsiek KH, Marconi VC, Ganesan A, Weintrob A, Barthel RV, Agan
BK, Group IDCRPHW (2010) Anal cancers among HIV-infected persons: HAART is not
slowing rising incidence. AIDS. (London, England 24:535 - Hunt PW (2012) HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep
9:139–147
10 Malignancies and HIV Infection